Takeda Biopharmaceuticals India Private Limited showcased its innovative digital healthcare solutions at the G20 Health Working Group meeting in Goa, India. The event aimed to create a digital health ecosystem, discuss innovations in healthcare, and explore how technology can aid continuing care and provide digital public health goods. Takeda Biopharmaceuticals presented its digital solutions, including MyPKFit, Synapse, and Athena, at the event.
MyPKFit is an FDA-approved application that offers personalized and interactive prophylaxis treatment options. Synapse is a platform designed to enhance awareness and knowledge-sharing among healthcare professionals, engaging over 4000 healthcare professionals through scientific exchange and educational initiatives. The Athena App MVP is a digital health solution that empowers patients to easily track, understand, and communicate simple, robust measures of Quality of Life (QOL).
Takeda Biopharmaceuticals is committed to leveraging digital solutions to transform healthcare and improve patient outcomes. Through their digital innovations, Takeda Biopharmaceuticals aims to drive healthcare access, enhance standards of care, and optimize patient benefits. Their participation in the G20 Health Working Group meeting provided an excellent platform to showcase their digital capabilities, explore potential collaborations with G20 member countries and relevant international organizations, and drive digital health innovation and adoption.